Shots:

• Pfizer launched a pilot program to support the state’s planning- deployment & administration of the COVID-19 vaccine candidate- to build on coordination with the relevant US agencies
• Pfizer has been working with US officials in OWS & the US CDC to help ensure that after potential authorization or approval- the Pfizer-bioNtech COVID-19 vaccine can reach those in most need as quickly and equitably as possible
• The BNT162b2 COVID-19 vaccine is not currently approved for distribution anywhere in the world- both collaborators are committed to developing these novel vaccines with preclinical & clinical data at the forefront of all their decision making

 ­ Ref: Pfizer | Image: Pfizer